èšåºèšºæå ¬è¡šãããæŽå¯
Theranosticsã¯ãæšççæ³ã§æšç蚺æãã¹ãã®çµã¿åãããå«ã¿ãŸãã ãŸããã³ã³ãããªã³èšºæãçµ±åå»çãDx/Rxã®ææºãè¬çåŠãšããŠç¥ãããŠããŸãã æ£è ã±ã¢èšç»ãžã®ã»ã©ãã¹ãã£ã¯ã¹ã®å®è£ (åæ²»çãšå ±ã«èšºæãã¹ããå©çšå¯èœãªéžæãããçŸæ£ã®å Žå)ã¯ãããå»çççµæãåäžãããããšãã§ããããŒãœãã©ã€ãºãããæ²»çã«å€ãããŸãããã©ãã¹ãã£ã¯ã¹ã¯ãç¹å®ã®èšºæãã¹ãã®äœ¿çšãå«ã¿ãŸããããã¯ãè «çãŸãã¯ãã®ä»ã®çŸæ£ã®åå ãšãªãç¹å®ã®ååæšçã瀺ããŠããŸãã ãã¹ãŠã®ç æ°ç çåŠã¯ã蚺æãã¹ãã®å©ããåããŠæšçã§ããç¹å®ã®çç©åŠççµè·¯ãå«ã¿ãŸãã ç¹å®ã®ååã®èšºæç»åã¯ãæ²»çè¬ã®å©ããåããŠæšç... ãã£ãšèŠã
ãŠã€ã«ã¹æ€æ»ã¯ãèçãã€ã³ãã«ãšã³ã¶ãHIVãæ§ææçãRCVãªã©ã®çŸæ£ã®æ©æçºèŠã«åœ¹ç«ã€èšºææ¹æ³ã§æ§æãããŠããŸãã ãŠã€ã«ã¹æ€æ»ã¯ããŠã€ã«ã¹ã®æåãæ žé žãããã³ç¹å®ã®æšæ¬ã®æäœã®æ€åºã®ããã«ãç¹å®ã®ãŠã€ã«ã¹ææã®ååšã確èªããããšãæ€èšããŸãã 100以äžã®ãŠã€ã«ã¹æ§çŸæ£ãç¹å®ãããŠããŸãããŠã€ã«ã¹ææã確èªããããã«ããŠã€ã«ã¹æ€æ»ã¯æ§ã ãªæ¹æ³ãåãå ¥ããŠããŸãã æåçäžæ žçææ³ã¯ãæåäžã®ã³ãããŒåœ¢æã«ãã£ãŠãŠã€ã«ã¹ã確èªãããé·ãé䜿çšãããŠããŸããã ãã®æ¹æ³ã¯åºãåãå ¥ããããå®è¡ããã®ã¯ç°¡åã§ãããç¹å®ã®ãŠã€ã«ã¹ã®ååšã確èªããã®ã«æ°æ¥ããæ°é±éãããããããã°ãã°æéãæ¶è²»ã... ãã£ãšèŠã
åžå°çŸæ£èšºæåžå Žãæ€æ»ã¿ã€ãå¥ïŒéºäŒåæ€æ»ãçååŠæ€æ»ãåå蚺æãç»å蚺æããã®ä»ïŒãæè¡å¥ïŒæ¬¡äžä»£ã·ãŒã±ã³ã·ã³ã°ïŒNGSïŒãããªã¡ã©ãŒãŒé£éåå¿ïŒPCRïŒããµã³ã¬ãŒã·ãŒã¯ãšã³ã·ã³ã°ããã€ã¯ãã¢ã¬ã€ã質éåæãå ç«ã¢ãã»ã€ããã®ä»ïŒãçŸæ£ã¿ã€ãå¥ïŒç¥çµçŸæ£ãä»£è¬æ§ããã³å åæ³çŸæ£ã è¡æ¶²çŸæ£ãå ç«çŸæ£ãå¿è¡ç®¡çŸæ£ãéºäŒæ§ãããçéªšæ Œç³»çŸæ£ããã®ä»ïŒããµã³ãã«ã¿ã€ãå¥ïŒè¡æ¶²ãåŸæ¶²ãå£è æãæ¶²ãå°¿ãçµç¹ãè³è髿¶²ïŒCSFïŒããã®ä»ïŒããšã³ããŠãŒã¶ãŒå¥ïŒèšºæç ç©¶æãç é¢ããã³èšºçæãç ç©¶ããã³åŠè¡æ©é¢ã補è¬ããã³ãã€ãªãã¯ãããžãŒïŒ äŒæ¥ããã®ä»)ãå°çå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢... ãã£ãšèŠã
ãšã«ã·ãã¢èšºæè¬åžå Žã補åã¿ã€ãå¥ïŒããããšè©Šè¬ãå¹å°ãæ©åšãšåæè£ 眮ãã³ã³ãããŒã«ãšæšæºããã®ä»ïŒãæ€æ»ã¿ã€ãå¥ïŒå忀æ»ãå¹é€æ€æ»ãè¡æž åŠçæ€æ»ãå ç«ã¢ãã»ã€ãçååŠæ€æ»ããã®ä»ïŒãçŸæ£ã¿ã€ãå¥ïŒãšã«ã·ãã¢çããã¹ããåœçµæ žèææçããã®ä»ïŒãæè¡å¥ïŒããªã¡ã©ãŒãŒãã§ãŒã³ïŒ åå¿ïŒPCRïŒããã«ããã¬ãã¯ã¹PCRãDNAãããŒããå ç«ã¢ãã»ã€ãã¢ãã¯ããŒãã«æäœãMALDI-TOF質éåæãã·ãŒã±ã³ã¹ããã®ä»ïŒããµã³ãã«ã¿ã€ãå¥ïŒäŸ¿ãµã³ãã«ãè¡æ¶²ãµã³ãã«ãçµç¹ãµã³ãã«ãé£åãµã³ãã«ãç°å¢ãµã³ãã«ããã®ä»ïŒãã¢ããªã±ãŒã·ã§ã³å¥ïŒèšåºèšºæãé£åå®å 𿀿»ãå ¬è¡è¡çç£èŠãç£å»åŠèšºæãç ç©¶ããã³åŠè¡... ãã£ãšèŠã
Hemostasisã®èšºæã¯é床ã®åºè¡ãåŒãèµ·ããhemostaticæ¬ é¥ãèå¥ããã®ã«åœ¹ç«ã¡ãŸãã Hemostasisã¯è¡ç®¡ã®å·å®³ã®åŸã§å·ã®æ²»çãå§ããããã£ã«ãã£ãŠæ¡çšãããè¡çºã®æåã®ã©ã€ã³ã§äœçšããäž»ããã·ãŒãžã£ã§ããããã«è¡ã®æµããé ããã忢ããããã»ã¹ã§ãã ããã»ã¹äžã«ãè¡æ¶²ã¯æ¶²äœç¶æ ãããŒã©ãã³ç¶æ ã«å€åããŸãã ãmostasis 㯠3 ã€ã®ã¡ã«ããºã ã«ãã£ãŠããã£ã§åæ§ã«vasoconstrictionãè¡å°æ¿ã®ãã©ã°ã®åœ¢æããã³è¡ååºãç¶æããŸãã 蚺æã¯ãæè¡äžã«éå°ãªåºè¡ã®åå ãäºæž¬ããé床ã®åºè¡ã®æŽå²ãæã€æ£è ã®æ¢è¡äžè¯ãèå¥ããã®ã«åœ¹ç«ã¡ãŸãã å»çå°éå®¶ã... ãã£ãšèŠã
ãã©ãŒã¹ãããã¯ãæ¯çްèã«åœ¢æãããæªæ§è «çã«ãã£ãŠç¹åŸŽä»ããããããã¯äœã®ä»ã®éšåã«åºããããšãã§ããŸãã ç¹æ®çã¯å¥³æ§ã§äž»ã«èгå¯ãããã ãã©ãŒã¹ãããã¯ãããã€ãã®æ€æ»ã®å©ããåããŠå»åž«ã«ãã£ãŠèšºæãããéå§ã®å Žæãšè «çã®è»¢ç§»ãäœã®äžéšã«èŠã€ããŸãã èžéšããã®çç¶ã¯ãèžéšã®å¡ãèžéšã®ç®èã®å¢æ®ãç®èã®ããã«ããã®æ¶²æµæŒããç®èã®ããããªã©ã®å€åãå«ãŸããŸãã ç¹æ®çã¯ãäœäœéåãã¢ã«ã³ãŒã«æ¶è²»éãè¥æºãæŽå¹Žæé害ãå®¶ææŽããã³åäŸã幎é·ã«æäŸããå±éºå åã®ããã«æ£åžžãªå人ã§éçºããããšãã§ããŸããç¹æ®çã¯ãæ¯å¹Žã®ãã³ã¢ã°ã©ã ãCTã¹ãã£ã³ãMRIãªã©ã®ç¹å®ã®ã¹ã¯ãªãŒãã³ã°æ€æ»ã«ãã£ãŠæ©... ãã£ãšèŠã
DNAæ³å»åŠåžå Žãã³ã³ããŒãã³ãå¥ïŒæ¶èåãã¢ãã©ã€ã¶ãŒããã³ã·ãŒã±ã³ãµãŒããœãããŠã§ã¢ããµãŒãã¹ïŒãæ¹æ³å¥ïŒããªã¡ã©ãŒãŒé£éåå¿å¢å¹ ããã£ãã©ãªãŒé»æ°æ³³åãæ¬¡äžä»£ã·ãŒã¯ãšã³ã·ã³ã°ããã®ä»ïŒãã¢ããªã±ãŒã·ã§ã³å¥ïŒç¯çœªæ€æ»ã芪åããã³å®¶ææ€æ»ãçœå®³è¢«å®³è ã®èº«å 確èªããã®ä»ïŒããšã³ããŠãŒã¶ãŒå¥ïŒæ³å·è¡æ©é¢ãæ³å»åŠç ç©¶æãç ç©¶ïŒ æ©é¢ãå»çããã³ç ç©¶æ©é¢ãæ³ããã³åžæ³å¶åºŠããã®ä»ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãããã³ã¢ããªã«ïŒ... ãã£ãšèŠã
å ç«ã¿ã³ãã¯è³ªã¯ãå ç«ã·ã¹ãã ã®æ©èœã®åœ¹å²ãæãããŠããé¢äžããŠããè¡æ¶²ã¿ã³ãã¯è³ªãæããŸãã ãããã®ã¿ã³ãã¯è³ªã¯ãç åäœãç©è³ªã«å¯Ÿããå ç«æŽ»æ§ãæããäžå¥åº·ãªç¶æ ã§ç æ°ã®èšºæã®æœåšçãªææšãšããŠäœçšããããšã«ãããè¡æ¶²æ¿åºŠã®ç°åžžãªå¢å ã衚瀺ããŠããŸãã å ç«ã¿ã³ãã¯è³ªã¯ãæåã®æå®³ãªåœ±é¿ãäžåããã®ã«åœ¹ç«ã€çްèãçµç¹ãŸãã¯èåšã«çµ±åäœã·ã¹ãã ã圢æããŸãã å ç«ã¿ã³ãã¯è³ªã¯ãææçãå¿è¡ç®¡çŸæ£ãè «çåŠçæ¡ä»¶ãå«ãããã€ãã®ç æ°ã®èšºæã«ã圹ç«ã¡ãŸããäžççãªå ç«ã¿ã³ãã¯è³ªèšºææ€æ»åžå Žã®å£²äžé«ãããã·ã¥ããæ ¢æ§çŸæ£ã®é«ãäºé²çå ç«ã¿ã³ãã¯è³ªèšºæè©ŠéšãµãŒãã¹ã®éèŠã®å¢å€§ã®ããã®äž»ãªçç±ã¯ãæ ¢æ§çŸ... ãã£ãšèŠã
ç£å»èšºæãããåžå Žã補åã¿ã€ãå¥ïŒå ç«èšºæ/è¿ éPOCãååPCRããã«ãèšåºååŠ/è¡æ¶²åŠè©Šè¬ããã¯ãç¹æ®ããããªã©ïŒãåç©ã¿ã€ãå¥ïŒæç©åç©ããã³å®¶çåç©ïŒãçšéå¥ïŒææçãçæ®ããã³çæ®èœåæ€æ»ãå åæ³ããã³ä»£è¬çŸæ£ãè «çåŠãäžè¬å¥åº·ããã³èšåºïŒ ç çåŠãªã©ïŒããšã³ããŠãŒã¶ãŒå¥ïŒåç©ç é¢ããã³ç é¢ãç£å»åŠèšºæ/åºæºç ç©¶æãçç£èŸ²å Žããã³ãã€ã³ããªãã±ã¢ïŒéå€è©ŠéšïŒãåŠè¡ç ç©¶æ©é¢ãªã©ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãããã³ã¢ããªã«ïŒ... ãã£ãšèŠã
ç±³åœã¯ãã¹ããªãžãŠã ã»ãã£ãã£ã·ã«æ€æ»åžå Žã補åå¥ïŒã¢ãã»ã€ãããããã³è©Šè¬ããã³æ©åšïŒãæ€æ»æè¡å¥ïŒåå/NAATæ€æ»ãå ç«æž¬å®/EIAæ€æ»ãªã©ïŒãæ€æ»ç°å¢å¥ïŒç é¢ã忥æœèšããã³åºæºç ç©¶æãé·æä»è·ããã³çç·Žçè·æœèšãªã©ïŒ... ãã£ãšèŠã
ã¿ã³ãã¯è³ªãã€ãªããŒã«ãŒåžå Žããã€ãªããŒã«ãŒã¿ã€ãå¥ïŒè «çåŠã¿ã³ãã¯è³ªãã€ãªããŒã«ãŒãå¿èã¿ã³ãã¯è³ªãã€ãªããŒã«ãŒãççæ§ããã³æè¡çã¿ã³ãã¯è³ªãã€ãªããŒã«ãŒãç¥çµåŠã¿ã³ãã¯è³ªãã€ãªããŒã«ãŒãèªå·±å ç«ã¿ã³ãã¯è³ªãã€ãªããŒã«ãŒã代è¬ã¿ã³ãã¯è³ªãã€ãªããŒã«ãŒãªã©ïŒãã¢ããªã±ãŒã·ã§ã³å¥ïŒãã€ãªããŒã«ãŒã®çºèŠãšæ€èšŒãåµè¬ãšèšåºè©Šéšã®ãµããŒããã¢ãã»ã€éçºãæäœéçºãªã©ïŒããšã³ããŠãŒã¶ãŒå¥ (IVD ããã³èšºæã¢ãã»ã€ã®ã¡ãŒã«ãŒã補è¬ããã³ãã€ãªãã¯ãããžãŒäŒæ¥ãCRO ããã³ãã€ãªããŒã«ãŒæ€æ»ãµãŒãã¹ãããã€ããŒããã®ä»)ãå°åå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãããã³ã¢ããªã«... ãã£ãšèŠã
ç¶¿æ£ã¯æè¡ãå»çã®äžéšã§ãããé«åºŠãªå»çã«ãããŠéèŠãªåœ¹å²ãæãããŠãããææ¥ç®±ãå·å£ã®æŽæµã泚å°éšäœãªã©ã«åºã䜿ãããŠãããç¶¿æ£ã¯åžåæ§ã®ããçŽ æã§ã§ããŠãããã¢ã«ã³ãŒã«ããšãŠçŽ ãã»ããªãããã³ã«ããã·ãžã³ãªã©ãé åãããŠããããšãããã ã¹ã¯ãã®äžçåžå ŽèŠæš¡ã¯2017幎ã«5å7,860äžç±³ãã«ãšè©äŸ¡ãããäºæž¬æéïŒ2018幎ïœ2026幎ïŒã®å¹Žå¹³åæé·çã¯6.6%ãšäºæ³ãããŠããã å³1.ã¹ã¯ãã®äžçåžå ŽèŠæš¡ïŒUS$ MnïŒãå°åå¥ã2017幎 åºå žã³ããŒã¬ã³ãããŒã±ããã€ã³ãµã€ãåæ æè¡ä»¶æ°ã®å¢å ãã¹ã¯ãåžå Žã®æé·ãä¿é²ããèŠèŸŒã¿ ã¹ã¯ãã¯å·å£ã®æŽæµã泚å°åã®æ¶æ¯ã«äœ¿çšã... ãã£ãšèŠã
IVDRèªèšŒåžå Žãããã€ã¹ã¿ã€ãå¥ïŒæ€æ»å®€ããŒã¹ããã³ãã€ã³ããªãã±ã¢ïŒãèŠå¶ã¯ã©ã¹å¥ïŒã¯ã©ã¹Iãã¯ã©ã¹IIãã¯ã©ã¹IIIãããã³ã¯ã©ã¹IVïŒã調éã¿ã€ãå¥ïŒç€Ÿå ããã³ã¢ãŠããœãŒã·ã³ã°ïŒããšã³ããŠãŒã¶ãŒå¥ïŒå»çæ©åšäŒç€Ÿãç é¢ããã³èšºçæã蚺æç ç©¶æ/ã»ã³ã¿ãŒãCDMOããã³CMOãªã©ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãããã³ãã®ä»ïŒ ã¢ããªã«)... ãã£ãšèŠã
èºç蚺æããã³ã¹ã¯ãªãŒãã³ã°åžå Žã¯USD 2,980.8ã§è©äŸ¡ããããšæšå®ãããŸã 2025幎ã®Mnã¯USD 5,845.8ã«éãããšäºæ³ããã 2032幎ã2025幎ãã2032幎ã«ãããŠ10.1%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºã ã°ããŒãã«èºãã蚺æããã³ã¹ã¯ãªãŒãã³ã°åžå Žã«é¢ããã¢ããªã¹ãã®æèŠ:èºããã¯ãèºã®çްèåè£ã«ãã£ãŠåŒãèµ·ããããç æ°ã§ãã èºããã«ããæ£è æ°ã®å¢å ã¯ãèºããã®èšºæãšã¹ã¯ãªãŒãã³ã°ãé«ããããšãæåŸ ãããŸãã ãããã£ãŠãèºããã®æ©æçºèŠãå¯èœã«ãã驿°çãªèºãã蚺æããã³ã¹ã¯ãªãŒãã³ã°æ¹æ³ãæäŸããããŸããŸãªè£œé æ¥è ã®ããã®æ©äŒãæäŸããŸããå³1. å šäœ... ãã£ãšèŠã
çèå æ§æåïŒCEAïŒåžå Žã補åå¥ïŒè©Šè¬ããã³ããããæ©åš/åæè£ çœ®ãæ¶èåïŒãæè¡å¥ïŒååŠçºå å ç«æž¬å®æ³ïŒCLIAïŒãé µçŽ çµåå ç«åžçæž¬å®æ³ïŒELISAïŒã黿°ååŠçºå å ç«æž¬å®æ³ïŒECLIAïŒãªã©ïŒãã¢ããªã±ãŒã·ã§ã³å¥ïŒãã蚺æãæ²»çã¢ãã¿ãªã³ã°ãåçºïŒ ã¢ãã¿ãªã³ã°ããã³ç ç©¶ã¢ããªã±ãŒã·ã§ã³ïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ã蚺æç ç©¶æãåŠè¡ç ç©¶æ©é¢ããã®ä»ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãããã³ã¢ããªã«ïŒ... ãã£ãšèŠã
ããããã³éãã蚺æçšã¢ãã¯ããŒãã«æäœåžå Žãæäœã¿ã€ãå¥ïŒããŠã¹æäœããŠãµã®æäœããã¡ã©æäœãããåæäœãå®å šããæäœãçµæãæäœããã®ä»ïŒãäœ¿çšæè¡å¥ïŒé µçŽ å ç«åžçæ³ïŒELISAïŒãååŠçºå å ç«æž¬å®æ³ïŒCLIAïŒããŠã§ã¹ã¿ã³ããããïŒWBïŒã å ç«çµç¹ååŠ (IHC)ãå ç«æ²é (IP)ãå ç«èå (IF)ãã©ãã©ã« ãã㌠ã¢ãã»ã€ãªã©)ãã¢ããªã±ãŒã·ã§ã³å¥ (ãããç£ç§ããã³ã°ç±ããã¯ã³ã°ãã¢ç±ãããªã³ãã¯ã¿ãŒ ãããªãæ¢ æ¯ãHIV (ããå ç«äžå šãŠã€ã«ã¹) ãªã©)ããšã³ã ãŠãŒã¶ãŒå¥ (èšåºããã³èšºæç ç©¶æãç é¢ããã€ãªå»è¬åäŒç€Ÿã ç ç©¶æ©é¢ãªã©ïŒãæµéãã£ãã«å¥ïŒãªãã©ã€ã³ããã³ãª... ãã£ãšèŠã
ããªã«ãã³è¡æ¶²æ€æ»åžå Žãæ€æ»ã¿ã€ãå¥ïŒç·ããªã«ãã³æ€æ»ãçŽæ¥ããªã«ãã³æ€æ»ã鿥ããªã«ãã³æ€æ»ïŒãã¢ããªã±ãŒã·ã§ã³å¥ïŒèçŸæ£ã®èšºæãšã¢ãã¿ãªã³ã°ãæ°çå é»çžã¹ã¯ãªãŒãã³ã°ãæº¶è¡æ§çŸæ£ãªã©ïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ã蚺æç ç©¶æãå»é¢ããã³èšºçæã倿¥æè¡ã»ã³ã¿ãŒãåšå® å»çæœèšãªã©ïŒãå°çå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
å»ç詊éšãµãŒãã¹ãéçºããç 究宀ã§èšèšããŠããŸãã å»è¬å補é ã»ç ç©¶ã»éçºã«ãããååŠçã»èšåºã»è£œé 段éãªã©ãã»ãŒå šãŠã®æ®µéã§ãã©ãã§ã®ãã«ã¹ã±ã¢ãã¹ããå¿ èŠã§ãã é圢æ ã®ããã»ã¹å質管ç(IPQC)ããŸã宿åã®å®è¡ããããã«åæãããã¹ãããã®ã«å©çšãããŸãã ãã«ã¹ã±ã¢ãã¹ãã¯ãå»ç補åã®æäžéã®å®å šæ§ãæå¹æ§ãå®å®æ§ãå¹åãæ€èšŒããæŽå©ãå«ã¿ãŸãã ãã«ã¹ã±ã¢ãã¹ãã©ãã¯ã補åãåžå Žã«æŸåºããåã«å®å šã«äœ¿çšã§ããããã«ãã¹ãããã®ã«åœ¹ç«ã¡ãŸãã ååŠãã¹ãã埮çç©æ€æ»ãæ¯æ§è©Šéšãå®å®æ§è©Šéšãããã³ä»ã¯ãå»ç詊éšã®å®éšå®€ãè¬ãæ²»çã®å®å šã確ä¿ããããã«æäŸãããµãŒãã¹ã®äžéšã§ãããã°ã... ãã£ãšèŠã